Wed, March 18, 2009
[ Wed, Mar 18th 2009 ] - Market Wire
Auxilium Pharmaceuticals, Inc.: Auxilium Pharmace .. icals to Present at Citi's 4th Annual Biotech Day
[ Wed, Mar 18th 2009 ] - Market Wire
Cypress Bioscience, Inc.: Cypress Bioscience, Inc .. en and Company 29th Annual Health Care Conference
Tue, March 17, 2009
[ Tue, Mar 17th 2009 ] - Market Wire
Stem Cell Therapy International, Inc.: Stem Cell .. national Inc. Announces Bridge Financing Obtained
[ Tue, Mar 17th 2009 ] - Market Wire
IDO Security, Inc.: IDO Security Announces Delivery of MagShoe to Multiple Clients
[ Tue, Mar 17th 2009 ] - Market Wire
Nanobac Pharmaceuticals: Nanobac Pharmaceuticals and Eureka Genomics Agree to Terms for Merger
[ Tue, Mar 17th 2009 ] - Market Wire
Edwards Lifesciences: Edwards Lifesciences Comple .. l Study Arm of U.S. Clinical Trial for Transcathe
[ Tue, Mar 17th 2009 ] - Market Wire
BioElectronics Corporation: BioElectronics Announces Menstrual Pain Clinical Study
[ Tue, Mar 17th 2009 ] - Market Wire
Chembio Diagnostics, Inc.: Chembio to Host Conference Call to Discuss 2008 Financial Results
[ Tue, Mar 17th 2009 ] - Market Wire
Eurand N.V.: Eurand Announces International Agree .. s for Once-Daily Extended Release Muscle Relaxant
Mon, March 16, 2009
[ Mon, Mar 16th 2009 ] - Market Wire
BIOLASE Technology, Inc.: BIOLASE Reports Fourth Quarter, Year-End Results
[ Mon, Mar 16th 2009 ] - Market Wire
Facet Biotech: Facet Biotech Provides 2009 Financial Guidance and Lowers Cash Utilization Estimate
[ Mon, Mar 16th 2009 ] - Market Wire
CV Therapeutics, Inc.: CV Therapeutics Announces .. College of Cardiology 58th Annual Scientific Ses
[ Mon, Mar 16th 2009 ] - Market Wire
Lakeland Industries, Inc.: EdgeWater Research Inv .. Highlights Lakeland Industries as Featured Stock
[ Mon, Mar 16th 2009 ] - Market Wire
Molecular Insight Pharmaceuticals, Inc. : Molecul .. nc. Announces Fourth Quarter and Year-End 2008 Fi
[ Mon, Mar 16th 2009 ] - Market Wire
Cypress Bioscience: Cypress Bioscience, Inc. Announces 2008 Financial Results
Sun, March 15, 2009
[ Sun, Mar 15th 2009 ] - Market Wire
Diagnostic Imaging International Corp.: Diagnosti .. ernational Corp.-Closes Acquisition and Financing
[ Sun, Mar 15th 2009 ] - Market Wire
FORTIS: Fortis holding pays no dividend for the 2008 financial year
[ Sun, Mar 15th 2009 ] - Market Wire
FORTIS: Memorandum of Understanding Between Fortis and Ping An Expired
Fri, March 13, 2009
[ Fri, Mar 13th 2009 ] - Market Wire
Midland Exploration Inc.: Midland Exploration Inc.: Amendment to Stock Option Plan
[ Fri, Mar 13th 2009 ] - Market Wire
Bennett Environmental Inc.: Bennett Environmental .. Reports Fourth Quarter and 2008 Year End Results
[ Fri, Mar 13th 2009 ] - Market Wire
SCOR: Standard & Poor's upgrades SCOR to "A"
[ Fri, Mar 13th 2009 ] - Market Wire
Molecular Insight Pharmaceuticals, Inc. : Molecul .. nc. to Announce Fourth Quarter, Year-End 2008 Fin
[ Fri, Mar 13th 2009 ] - Market Wire
San Anton Resource Corporation: San Anton Announces Kings Minerals Share Purchase Plan Offer
[ Fri, Mar 13th 2009 ] - Market Wire
Lpath, Inc.: Lpath to Hire Clinical Head
[ Fri, Mar 13th 2009 ] - Market Wire
MoneyTV; Hydrogen Hybrid Corporation; AlphaTrade. .. ; Cord Blood America, Inc.: MoneyTV, Week of 3/13
Thu, March 12, 2009
[ Thu, Mar 12th 2009 ] - Market Wire
Pacific Energy Resources Ltd.: Court Enters Order .. Trading in Stock of Pacific Energy Resources Ltd.
[ Thu, Mar 12th 2009 ] - Market Wire
AspenBio Pharma, Inc.: AspenBio Pharma to Proceed With FDA 510(k) Application for AppyScore(TM)
[ Thu, Mar 12th 2009 ] - Market Wire
Harte Gold Corp.: Harte Gold Corp. Corporate Update
[ Thu, Mar 12th 2009 ] - Market Wire
Sanguine Corporation: Sanguine Corp Announces Let .. mmitment to License PHER-O2 to Rockland Technimed
[ Thu, Mar 12th 2009 ] - Market Wire
Pacific Energy Resources Ltd.: TSX Suspends Trading; Subsequent Delisting
[ Thu, Mar 12th 2009 ] - Market Wire
AspenBio Pharma, Inc.: AspenBio Pharma to Host Investor Update Call Today at 4:30 PM ET
[ Thu, Mar 12th 2009 ] - Market Wire
Urigen Pharmaceuticals: Urigen Pharmaceuticals, I .. rey G. Proctor, M.D. to Scientific Advisory Board
[ Thu, Mar 12th 2009 ] - Market Wire
Electro-Optical Sciences, Inc.: Electro-Optical S .. Data From MelaFind(R) Pivotal Study Presented at
Wed, March 11, 2009
[ Wed, Mar 11th 2009 ] - Market Wire
Molecular Insight Pharmaceuticals, Inc. : Molecul .. Protocol Assessment Approval From FDA for Phase 2
[ Wed, Mar 11th 2009 ] - Market Wire
PDL BioPharma: PDL BioPharma Elects Frederick Frank and Jody Lindell to Its Board of Directors
[ Wed, Mar 11th 2009 ] - Market Wire
DUSA Pharmaceuticals, Inc.: DUSA Pharmaceuticals .. ll Year 2008 Corporate Highlights and Financial R
Tue, March 10, 2009
[ Tue, Mar 10th 2009 ] - Market Wire
Watson Pharmaceuticals: Watson to Present at Cowen and Company 29th Annual Health Care Conference
[ Tue, Mar 10th 2009 ] - Market Wire
Trinity Biotech: Trinity Biotech Announces Quarter 4 Results
[ Tue, Mar 10th 2009 ] - Market Wire
Allana Resources Inc.: Allana Resources Appoints .. a Biya Senior Vice President Business Development
[ Tue, Mar 10th 2009 ] - Market Wire
AVI BioPharma, Inc.: AVI BioPharma Announces Fourth Quarter and Year End 2008 Financial Results
[ Tue, Mar 10th 2009 ] - Market Wire
Vyteris, Inc.: Vyteris Initiates Phase II Clinica .. nfertility Treatment Using Smart Patch Technology
[ Tue, Mar 10th 2009 ] - Market Wire
Eurand N.V.: FDA Grants Orphan Drug Designation for EUR-1073
[ Tue, Mar 10th 2009 ] - Market Wire
Auxilium Pharmaceuticals, Inc.: Auxilium Pharmace .. en and Company 29th Annual Health Care Conference
Mon, March 9, 2009
[ Mon, Mar 09th 2009 ] - Market Wire
Facet Biotech: Facet Biotech Announces March 16 W .. Full Year 2008 Financial Results Conference Call
[ Mon, Mar 09th 2009 ] - Market Wire
Pacific Energy Resources Ltd.: Pacific Energy Res .. iles for Chapter 11 to Facilitate a Restructuring
[ Mon, Mar 09th 2009 ] - Market Wire
Trinity Biotech: Trinity Biotech Announces Commencement of TRI-stat(TM) CLIA Trials
[ Mon, Mar 09th 2009 ] - Market Wire
Biomoda, Inc.: Biomoda Approved to Begin Screening Veterans for Lung Cancer
[ Mon, Mar 09th 2009 ] - Market Wire
PDL BioPharma: PDL BioPharma to Present at the Co .. h Annual Health Care Conference on March 18, 2009
[ Mon, Mar 09th 2009 ] - Market Wire
Electro-Optical Sciences, Inc.: Electro-Optical S .. on at the Cowen and Company 29th Annual Health Ca
[ Mon, Mar 09th 2009 ] - Market Wire
Dragon Pharmaceutical Inc.: Dragon Pharmaceutical .. Pharmaceutical Client Increases Clavulanic Acid O
[ Mon, Mar 09th 2009 ] - Market Wire
XELR8 Holdings, Inc.: XELR8 Holdings Begins Trading Under New Symbol XELR
[ Mon, Mar 09th 2009 ] - Market Wire
Wellstar International, Inc.: Wellstar International, Inc. Secures $250,000 of New Financing
[ Mon, Mar 09th 2009 ] - Market Wire
Human Genome Sciences, Inc.: Human Genome Science .. in Second of Two Phase 3 Trials of Albuferon(R) i
[ Mon, Mar 09th 2009 ] - Market Wire
SciClone Pharmaceuticals, Inc.: SciClone Complete .. e in Phase 2 Trial for RP101 in Late-Stage Pancre
[ Mon, Mar 09th 2009 ] - Market Wire
Cypress Bioscience, Inc.: Cypress Bioscience, Inc .. at Barclays Capital Global Healthcare Conference
Fri, March 6, 2009
[ Fri, Mar 06th 2009 ] - Market Wire
SCOR: SCOR announces the publication of its 2008 Registration Document
[ Fri, Mar 06th 2009 ] - Market Wire
Bennett Environmental Inc.: Bennett Environmental Inc. Announces Appeal Result
[ Fri, Mar 06th 2009 ] - Market Wire
MediSys Corporation: MediSys Corporation Launches New Web Site
[ Fri, Mar 06th 2009 ] - Market Wire
DUSA Pharmaceuticals, Inc.: DUSA Pharmaceuticals, .. er and Full Year 2008 Financial Results and Corpo
[ Fri, Mar 06th 2009 ] - Market Wire
MDRNA, Inc.: MDRNA, Inc. Receives Delisting Notice From NASDAQ and Requests Hearing
[ Fri, Mar 06th 2009 ] - Market Wire
Trinity Biotech: Trinity Biotech plc to Announce .. uarter and Fiscal 2008 Year-End Financial Results
[ Fri, Mar 06th 2009 ] - Market Wire
Skyepharma PLC: Skyepharma PLC announces Conversion of Bonds
[ Fri, Mar 06th 2009 ] - Market Wire
Asher Xino Corporation: AsherXino Corporation Appoints Jack Webb Vice Chairman
Thu, March 5, 2009
[ Thu, Mar 05th 2009 ] - Market Wire
BIOLASE Technology, Inc.: BIOLASE Announces Appointment of David Mulder to CEO
[ Thu, Mar 05th 2009 ] - Market Wire
Cord Blood America: Cord Blood America Top Stock .. Global Stem Cell and Regenerative Medicine Index
[ Thu, Mar 05th 2009 ] - Market Wire
Skyepharma PLC: Skyepharma PLC announces Consultation Process
[ Thu, Mar 05th 2009 ] - Market Wire
CV Therapeutics, Inc.: CV Therapeutics Reports Ph .. Concept for CVT-3619, a Novel Potential Treatment
[ Thu, Mar 05th 2009 ] - Market Wire
Eurand N.V.: Eurand Reports Recent Developments a .. urth Quarter and Full-Year 2008 Financial Results
Wed, March 4, 2009
[ Wed, Mar 04th 2009 ] - Market Wire
Wellstar International, Inc.: Wellstar Internatio .. l, Inc. Signs LOI for up to $1 Million in Funding
[ Wed, Mar 04th 2009 ] - Market Wire
Constellation Software Inc.: Constellation Softwa .. the Fourth Quarter and Year Ended December 31, 2
[ Wed, Mar 04th 2009 ] - Market Wire
Trinity Biotech: Trinity Biotech Announces Its Fi .. st 3 Destiny Max Placements in the United Kingdom
[ Wed, Mar 04th 2009 ] - Market Wire
Eurand N.V.: Eurand to Present at Cowen Health Care Conference
[ Wed, Mar 04th 2009 ] - Market Wire
Syneron Medical Ltd.: Syneron(TM) Unveils New eMa .. ctional Treatments for Darker Skin Types at Ameri
[ Wed, Mar 04th 2009 ] - Market Wire
AVI BioPharma, Inc.: AVI BioPharma Announces Four .. d Year End 2008 Financial Results Conference Call
Tue, March 3, 2009
[ Tue, Mar 03rd 2009 ] - Market Wire
SCOR: SCOR records solid results with a net incom .. ed by an outstanding liquidity position of EUR 3.
[ Tue, Mar 03rd 2009 ] - Market Wire
XELR8 Holdings, Inc.: XELR8 Holdings Loses Appeal at the NYSE Alternext
[ Tue, Mar 03rd 2009 ] - Market Wire
Myriad Genetics: Myriad Genetics to Present at Cowen Health Care Conference on March 17, 2009
[ Tue, Mar 03rd 2009 ] - Market Wire
Anaconda Mining Inc.: Anaconda Announces Initiati .. of Arbitration Process With JV Partner New Island
[ Tue, Mar 03rd 2009 ] - Market Wire
Given Imaging: Given Imaging Sets Dividend Distribution Date
[ Tue, Mar 03rd 2009 ] - Market Wire
CV Therapeutics, Inc.: Ranexa(R) Now Available in United Kingdom and Germany
[ Tue, Mar 03rd 2009 ] - Market Wire
X PRIZE Foundation: X PRIZE Foundation, WellPoint .. Hold Advisory Summit to Propose Ideas for Health
[ Tue, Mar 03rd 2009 ] - Market Wire
FONAR Corporation: FONAR Enters Africa and Middle .. kets With Sale to Leading Medical Center in Libya
[ Tue, Mar 03rd 2009 ] - Market Wire
SciClone Pharmaceuticals, Inc.: SciClone Reports .. Results for the Fourth Quarter and Year-End 2008
Mon, March 2, 2009
[ Mon, Mar 02nd 2009 ] - Market Wire
Auxilium Pharmaceuticals, Inc.: Auxilium Submits .. for XIAFLEX(TM) for the Treatment of Dupuytren's
[ Mon, Mar 02nd 2009 ] - Market Wire
Constellation Software Inc.: Midwest Energy Inc. .. ary of Constellation Software's Harris Subsidiary
[ Mon, Mar 02nd 2009 ] - Market Wire
Sun Healthcare Group, Inc.: Sun Healthcare Group, .. Earnings; Strong Results Led by Growth in Skilled
[ Mon, Mar 02nd 2009 ] - Market Wire
Wellstar International, Inc.: Wellstar/TMI to Uti .. Board Members in the Marketing of Imaging Systems
[ Mon, Mar 02nd 2009 ] - Market Wire
PDL BioPharma: PDL BioPharma Announces Fourth Quarter and Full Year 2008 Financial Results
[ Mon, Mar 02nd 2009 ] - Market Wire
NeuroInvestment: Migraine Therapeutics Reviewed by NeuroInvestment
[ Mon, Mar 02nd 2009 ] - Market Wire
Hansen Medical, Inc.: Hansen Medical Announces St .. anced Cardiac Therapeutics and Procurement of Cer
[ Mon, Mar 02nd 2009 ] - Market Wire
Watson Pharmaceuticals: Watson to Present at Barclays Capital Global Healthcare Conference
[ Mon, Mar 02nd 2009 ] - Market Wire
Pentaho Corporation: Cardiac Science Selects Pentaho to Streamline Information Integration
[ Mon, Mar 02nd 2009 ] - Market Wire
Targeted Genetics: Targeted Genetics Provides Business Update and Announces Extended Cash Horizon
Fri, February 27, 2009
[ Fri, Feb 27th 2009 ] - Market Wire
Rexahn Pharmaceuticals Receives Notice from NYSE Alternext US LLC
[ Fri, Feb 27th 2009 ] - Market Wire
Nanobac Pharmaceuticals: Nanobac Message to Shareholders
[ Fri, Feb 27th 2009 ] - Market Wire
UnitedHealth Group to Open New Service Center in Harlingen, Texas
[ Fri, Feb 27th 2009 ] - Market Wire
Healthways Participates in New NCQA Wellness & Health Promotion Accreditation Program
[ Fri, Feb 27th 2009 ] - Market Wire
Health Net Federal Services Wins Department of Ve .. d Outpatient Clinic Contract in Durango, Colorado
[ Fri, Feb 27th 2009 ] - Market Wire
CONMED Corporation: CONMED Corporation Sets Annual Meeting Date
[ Fri, Feb 27th 2009 ] - Market Wire
AMAG Pharmaceuticals, Inc. Reports Financial Resu .. for the Quarter and Year Ended December 31, 2008
[ Fri, Feb 27th 2009 ] - Market Wire
BIOLASE Technology, Inc.: BIOLASE Launches New Wa .. se(R) MD Turbo(TM) All-Tissue Dental Laser System
[ Fri, Feb 27th 2009 ] - Market Wire
Celldex Reports Fourth Quarter and Fiscal 2008 Financial Results
[ Fri, Feb 27th 2009 ] - Market Wire
EPIX Pharmaceuticals Announces Resignation of Chief Business Officer
[ Fri, Feb 27th 2009 ] - Market Wire
Panacos Announces Voluntary Decision to Delist Co .. aq and Terminate SEC Registration of Common Stock
[ Fri, Feb 27th 2009 ] - Market Wire
Alexion Joins NORD and EURORDIS in Supporting the Goals of Rare Disease Day
Thu, February 26, 2009
[ Thu, Feb 26th 2009 ] - Market Wire
Somaxon Receives Complete Response Letter from the FDA for Silenor® (doxepin)
[ Thu, Feb 26th 2009 ] - Market Wire
European Authorities Approve Larger-Scale Production of Genzyme?s Myozyme
[ Thu, Feb 26th 2009 ] - Market Wire
A Senior Cancer Researcher Joins PhytoMedical on .. uccessful Preclinical Study on Human Brain Cancer
[ Thu, Feb 26th 2009 ] - Market Wire
ArQule to Report Fiscal 2008 Financial Results on March 5, 2009
[ Thu, Feb 26th 2009 ] - Market Wire
Clinical Data, Inc. Announces $50 Million Convertible Debt Financing
[ Thu, Feb 26th 2009 ] - Market Wire
Optimer Pharmaceuticals Announces Publication in .. rulifloxacin?s Antibacterial Activity against Inf
[ Thu, Feb 26th 2009 ] - Market Wire
70 Abstracts Evaluatingthe Potential of Celgene P .. Be Presented at the 12th International Myeloma W
[ Thu, Feb 26th 2009 ] - Market Wire
Invitrogen Earns AmeriStar Award for GIBCO Cell Culture Bottle Design
[ Thu, Feb 26th 2009 ] - Market Wire
Conceptus Appoints John L. Bishop to Board of Directors
[ Thu, Feb 26th 2009 ] - Market Wire
Natus Medical Announces Record 2008 Fourth Quarter and Full Year Results
[ Thu, Feb 26th 2009 ] - Market Wire
Regeneron Reports Full Year and Fourth Quarter 2008 Financial and Operating Results
[ Thu, Feb 26th 2009 ] - Market Wire
Zacks Bull & Bear of the Day Highlights: Pozen In .. Corp., Agrium, CF Industries and Terra Industries
Wed, February 25, 2009
[ Wed, Feb 25th 2009 ] - Market Wire
Adolor Corporation Reports Year-End 2008 Financial Results
[ Wed, Feb 25th 2009 ] - Market Wire
Quidel Reports Fourth Quarter and Full Year 2008 Results
[ Wed, Feb 25th 2009 ] - Market Wire
Biovail Receives Requisition from Dissident Shareholder Eugene Melnyk
[ Wed, Feb 25th 2009 ] - Market Wire
Data on PolyMedix Antimicrobial Compounds Present .. robiology 7th Annual Biodefense and Emerging Dise
[ Wed, Feb 25th 2009 ] - Market Wire
Anika Therapeutics Announces Date of Fourth Quart .. d Year End 2008 Financial Results Conference Call
[ Wed, Feb 25th 2009 ] - Market Wire
Dyax Corp. Announces Fourth Quarter and Year End 2008 Financial Results
[ Wed, Feb 25th 2009 ] - Market Wire
Adipose-Derived Stem and Regenerative Cells Preve .. ity and Reduce Kidney Damage in Preclinical Study
[ Wed, Feb 25th 2009 ] - Market Wire
Ceragenix and Pediapharm Enter Into Distribution and Supply Agreement for EpiCeram®
[ Wed, Feb 25th 2009 ] - Market Wire
Alexion?s Soliris(R) (eculizumab) Receives Market .. g Approval in Australia for All Patients with PNH
[ Wed, Feb 25th 2009 ] - Market Wire
A.P. Pharma Appoints John B. Whelan as Chief Financial Officer
[ Wed, Feb 25th 2009 ] - Market Wire
Zacks Industry Outlook Highlights: Immucor
[ Wed, Feb 25th 2009 ] - Market Wire
Elan Announces Further Alignment of Resources as Part of On-Going Strategic Review Process
Tue, February 24, 2009
[ Tue, Feb 24th 2009 ] - Market Wire
Luminex Corporation Announces the Release of xPONENT® 3.1 Software
[ Tue, Feb 24th 2009 ] - Market Wire
HemaCare Corporation: HemaCare Reports Record 4th Quarter and 2008 Revenues
[ Tue, Feb 24th 2009 ] - Market Wire
Free Electronic Prescribing Service Now Available to San Antonio Physicians
[ Tue, Feb 24th 2009 ] - Market Wire
Health Net Announces New Enterprise-Wide Quality Office
[ Tue, Feb 24th 2009 ] - Market Wire
Assisted Living Concepts, Inc.: Assisted Living C .. Fourth Quarter and Full Year Results -- Solid Fou
[ Tue, Feb 24th 2009 ] - Market Wire
St. Jude Medical Receives Australian TGA Regulato .. for the World?s Smallest and Longest-Lasting Rec
[ Tue, Feb 24th 2009 ] - Market Wire
Cypress Bioscience Inc.: Cypress Bioscience, Inc. .. ne Technology Platform From Cellatope Corporation
[ Tue, Feb 24th 2009 ] - Market Wire
CPEX Pharmaceuticals Initiates Phase II Clinical Trial of Nasulin®
[ Tue, Feb 24th 2009 ] - Market Wire
Salix Pharmaceuticals Announces 4Q2008 and FY2008 Financial Results Conference Call and Webcast
[ Tue, Feb 24th 2009 ] - Market Wire
Resumen: Biogen Idec nombra a Michael Lytton vicepresidente ejecutivo de desarrollo empresarial
[ Tue, Feb 24th 2009 ] - Market Wire
Bioject Enters into a Collaborative Research Agre .. IAVI for the Delivery of an HIV Vaccine Candidate
[ Tue, Feb 24th 2009 ] - Market Wire
Acorda Therapeutics Reports Fourth Quarter and Full Year 2008 Financial Results
Mon, February 23, 2009
[ Mon, Feb 23rd 2009 ] - Market Wire
Celldex to Report Fourth Quarter and Fiscal 2008 Financial Results on February 27, 2009
[ Mon, Feb 23rd 2009 ] - Market Wire
Medtronic Acquires Ventor Technologies Ltd.
[ Mon, Feb 23rd 2009 ] - Market Wire
Aradigm Announces $4.1 Million Registered Direct Offering
[ Mon, Feb 23rd 2009 ] - Market Wire
Flamel Technologies Announces Appointment of Jeffery S. Vick as Chief Business Officer
[ Mon, Feb 23rd 2009 ] - Market Wire
CytRx?s Arimoclomol to be Administered in a Phase .. l Trial in a Subset of Patients with Familial ALS
[ Mon, Feb 23rd 2009 ] - Market Wire
Celsion to Report Clinical Trial Update of Thermo .. Breast Cancer Study at the Society for Thermal Me
[ Mon, Feb 23rd 2009 ] - Market Wire
Optimer Pharmaceuticals Appoints Industry Veteran .. s Chief Scientific Officer and Peter E. Grebow to
[ Mon, Feb 23rd 2009 ] - Market Wire
GTx Initiates Phase I Clinical Trial for GTx-758, .. ng Hormone Inhibitor for Advanced Prostate Cancer
[ Mon, Feb 23rd 2009 ] - Market Wire
Japanese Researchers Find CSA-13 May Be Useful fo .. reatment of Dental Caries and Periodontal Disease
[ Mon, Feb 23rd 2009 ] - Market Wire
CytoCore Signs Agreement to Sell Synermed?s General Cytology Preservative with SoftPAP
[ Mon, Feb 23rd 2009 ] - Market Wire
Cardima Completes Second Atrial Fibrillation Training Session in Thailand
Sun, February 22, 2009
[ Sun, Feb 22nd 2009 ] - Market Wire
Astellas Pharma Issues Statement Regarding CV Therapeutics Rejection of All-Cash Proposal
Fri, February 20, 2009
[ Fri, Feb 20th 2009 ] - Market Wire
PDL BioPharma: PDL BioPharma to Host Fourth-Quart .. inancial Results Conference Call on March 2, 2009
[ Fri, Feb 20th 2009 ] - Market Wire
Study of Genzyme Oral Compound for Gaucher Disease Meets Primary Endpoint
[ Fri, Feb 20th 2009 ] - Market Wire
Humana Names Paul Kusserow Senior Vice President and Chief Strategy Officer
[ Fri, Feb 20th 2009 ] - Market Wire
Orthovita to Present at the Canaccord Adams Musculoskeletal Conference
[ Fri, Feb 20th 2009 ] - Market Wire
ARIAD Announces $24.3 Million Registered Direct Financing
[ Fri, Feb 20th 2009 ] - Market Wire
Targanta Enters into Memorandum of Understanding to Resolve Shareholder Lawsuit
[ Fri, Feb 20th 2009 ] - Market Wire
EnteroMedics Announces $15.89 Million Private Placement
[ Fri, Feb 20th 2009 ] - Market Wire
StemCells, Inc. Comments on PLoS Medicine Article Concerning Cell Transplants in Russia
[ Fri, Feb 20th 2009 ] - Market Wire
EPIX Pharmaceuticals to Present Preclinical Data for Two Programs at Keystone Symposia
[ Fri, Feb 20th 2009 ] - Market Wire
WellCare Responding to Concerns Raised by Centers for Medicare & Medicaid Services
[ Fri, Feb 20th 2009 ] - Market Wire
Strategic Re-alignment Continues - Fourth Quarter 2008 Financial Results Reported
Thu, February 19, 2009
[ Thu, Feb 19th 2009 ] - Market Wire
La Jolla Pharmaceutical Company Announces Reduction in Workforce and Evaluates Strategic Options
[ Thu, Feb 19th 2009 ] - Market Wire
Metropolitan Health Networks to Announce Fourth Quarter and Fiscal 2008 Results
[ Thu, Feb 19th 2009 ] - Market Wire
Medtronic Board Approves Fourth Quarter Cash Dividend
[ Thu, Feb 19th 2009 ] - Market Wire
XELR8 Holdings, Inc.: XELR8 Holdings, Inc. Retain .. LC to Implement Global Investor Relations Program
[ Thu, Feb 19th 2009 ] - Market Wire
AVI BioPharma, Inc.: AVI BioPharma Announces Trea .. temic Clinical Trial of AVI-4658 for Treatment of
[ Thu, Feb 19th 2009 ] - Market Wire
Seattle Genetics Initiates Pivotal Trial of SGN-35 for Hodgkin Lymphoma
[ Thu, Feb 19th 2009 ] - Market Wire
MiddleBrook Pharmaceuticals Schedules Conference .. 08 Fourth Quarter and Full-Year Financial Results
[ Thu, Feb 19th 2009 ] - Market Wire
Enzon Reports 2008 Results
[ Thu, Feb 19th 2009 ] - Market Wire
Invacare Corporation Announces Appointment of Dale C. LaPorte to Board of Directors
[ Thu, Feb 19th 2009 ] - Market Wire
Forensic DNA Shown to Lower Crime Rates and Decrease Property Loss
[ Thu, Feb 19th 2009 ] - Market Wire
Antigenics Reports Fourth Quarter and Year-End 2008 Financial Results and Highlights
Wed, February 18, 2009
[ Wed, Feb 18th 2009 ] - Market Wire
Resumen: Estudio revelador publicado en The Lance .. ® de Celgene demuestra supervivencia sin preceden
[ Wed, Feb 18th 2009 ] - Market Wire
DelSite, Inc: DelSite Announces Intention to Lice .. nufacturing Rights, Fields of Use and Territories
[ Wed, Feb 18th 2009 ] - Market Wire
FONAR Corporation: FONAR Reports Profit and 2nd Quarter Fiscal 2009 Financial Results
[ Wed, Feb 18th 2009 ] - Market Wire
ReGen Biologics Initiates Training Program for U.S. Surgeons
[ Wed, Feb 18th 2009 ] - Market Wire
Auxilium Pharmaceuticals, Inc.: Auxilium Pharmace .. h Quarter and Full Year 2008 Financial Results, a
[ Wed, Feb 18th 2009 ] - Market Wire
Allion Healthcare Announces Date of Fourth Quarter 2008 Financial Results and Conference Call
[ Wed, Feb 18th 2009 ] - Market Wire
Dyax Corp. to Host Fourth Quarter and Year End 2008 Earnings Call and Webcast
[ Wed, Feb 18th 2009 ] - Market Wire
IsoRay, Inc. Announces Distribution Agreement with BrachySciences
[ Wed, Feb 18th 2009 ] - Market Wire
GTx Announces Toremifene 80 mg NDA Accepted for Review by FDA
[ Wed, Feb 18th 2009 ] - Market Wire
Emeritus Announces Resignation of Chief Operating Officer
[ Wed, Feb 18th 2009 ] - Market Wire
High-Throughput Genotyping of AML Patients for a .. eptor May Significantly Improve Treatment Outcome
Tue, February 17, 2009
[ Tue, Feb 17th 2009 ] - Market Wire
Teva Invites Public to Listen to Investor & Analyst Meeting Webcast
[ Tue, Feb 17th 2009 ] - Paula Catchpole
New Study From Plastic and Reconstructive Surgery Journal Shows How Not To Look Old.
[ Tue, Feb 17th 2009 ] - Market Wire
Remedent, Inc.: Remedent Engages Liolios Group to Lead New Investor Relations Program
[ Tue, Feb 17th 2009 ] - Market Wire
Depomed Initiates Phase I Trial for DM-1992 Progr .. lowing Positive Results of Preclinical Studies Sp
[ Tue, Feb 17th 2009 ] - Market Wire
Alnylam to Webcast Conference Call Discussing Fourth Quarter and 2008 Financial Results
[ Tue, Feb 17th 2009 ] - Market Wire
Affymax Announces $42 Million Private Placement
[ Tue, Feb 17th 2009 ] - Market Wire
Phase 1 Trial Begins for Investigational New Drug for MDR Gram-negative Infections
[ Tue, Feb 17th 2009 ] - Market Wire
Natus Medical to Hold 2008 Fourth Quarter Financial Results Conference Call on February 26
[ Tue, Feb 17th 2009 ] - Market Wire
California Hospital Implements ZOLL AutoPulse
[ Tue, Feb 17th 2009 ] - Market Wire
Acorda Therapeutics to Host Conference Call to Re .. Year 2008 Financial Results on February 24, 2009
[ Tue, Feb 17th 2009 ] - Market Wire
GTX Reports Fourth Quarter and Year End 2008 Results
[ Tue, Feb 17th 2009 ] - Market Wire
Zacks Bull & Bear of the Day Highlights: Baxter I .. nal, Marriott International, UDR, AIV and Vornado
Mon, February 16, 2009
[ Mon, Feb 16th 2009 ] - Market Wire
Constellation Software Inc.: Constellation Softwa .. Call to Discuss Fourth Quarter and Annual Results
[ Mon, Feb 16th 2009 ] - Market Wire
Wright Medical Group, Inc. to Participate in The Canaccord Adams Musculoskeletal Conference

Facet Biotech: Facet Biotech Elects Kurt von Emster to Board of Directors


//health-fitness.news-articles.net/content/2009/ .. lects-kurt-von-emster-to-board-of-directors.html
Published in Health and Fitness on Tuesday, February 24th 2009 at 13:58 GMT, Last Modified on 2009-02-24 13:58:49 by Market Wire   Print publication without navigation


REDWOOD CITY, CA--(Marketwire - February 24, 2009) - Facet Biotech Corporation (NASDAQ: [ FACT ]) today announced the election of Kurt von Emster as a member of its board of directors.

"We are pleased to welcome Kurt, a biotechnology veteran, to Facet's board," said Brad Goodwin, chairperson of Facet Biotech's board of directors. "Kurt's thorough understanding of the industry and his solid financial and investment expertise will provide a unique perspective as we work to establish Facet as a promising, oncology-focused biotechnology company."

Since November 2000, von Emster has been Managing Director of MPM BioEquities and serves as Portfolio Manager for the MPM BioEquities Fund. From July 1989 to November 2000, he was with the Franklin Templeton Group, most recently as a Vice President and Portfolio Manager. He is currently a member of the board of directors at Somaxon Pharmaceuticals, Inc., a public biotechnology company. He is a Chartered Financial Analyst (CFA), a member of the Association for Investment Management and Research and of the Security Analysts of San Francisco, and received his B.S. from the University of California at Santa Barbara.

About Facet Biotech

Facet Biotech is a biotechnology company dedicated to advancing its pipeline of four clinical-stage products and leveraging its research and development capabilities to identify and develop new oncology drugs. Facet Biotech Corporation launched in December 2008 as a spin-off from PDL BioPharma, Inc.

NOTE: Facet Biotech and the Facet Biotech logo are considered trademarks of Facet Biotech Corporation.


Publication Contributing Sources